{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-415015","form_type":"8-K","ticker":"RGEN","cik":"0000730272","company_name":"REPLIGEN CORP","filed_at":"2026-10-06T13:14:18+00:00","discovered_at":"2026-10-06T13:15:00.324966+00:00","generated_at":"2026-10-12T16:29:37.975755+00:00","sec_items":["2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Repligen closes BioLife Solutions buy for $11.25 cash plus 0.1442 RGEN shares per share","bullets":["BioLife stockholders received $11.25 in cash plus 0.1442 shares of Repligen common stock per share, with cash in lieu of fractional shares.","Mergers closed October 6, 2026 under the July 21, 2026 agreement; BioLife ceased to exist as a separate legal entity and became a Repligen subsidiary.","BioLife Common Stock is being delisted from Nasdaq via Form 25, with a Form 15 planned to suspend reporting obligations under Sections 13 and 15(d).","BioLife's CryoStor-led biopreservation media serves 18 commercially approved therapies and the majority of U.S. commercially sponsored cell-based therapy trials.","Repligen says the deal adds a high-margin consumables franchise with recurring revenue and Asia Pacific reach; 2026 outlook impact to be detailed on the Q3 2026 earnings call."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-415015","json":"https://secwatch.observer/filing/0001193125-26-415015.json","markdown":"https://secwatch.observer/filing/0001193125-26-415015.md","text":"https://secwatch.observer/filing/0001193125-26-415015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730272/000119312526415015/0001193125-26-415015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730272/000119312526415015/d240327d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:29:37.975755+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}